by Eric Christianson | Oct 6, 2024 | Clinical Pharmacy News and New Drug Updates, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Fezolinetant (Veozah) is a central nervous system agent that works as an antagonist at the neurokinin 3 (NK3) receptor. This action inhibits neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron which alters activity in the thermoregulatory...
by Eric Christianson | Sep 29, 2024 | Gastrointestinal Medication and Disease State Clinical Pearls
Proton Pump Inhibitors are one of the most commonly used medication classes for GERD and other gastrointestinal disorders. While they don’t have a ton of significant drug interactions, there are some important ones that you should know. I outline my top 5 PPI...
by Eric Christianson | Sep 22, 2024 | Endocrine Medication and Disease State Clinical Pearls
Fluctuations in blood sugars can be very distressing for patients. This is especially true in patients who have adequate control of their diabetes. Adverse effects can lead to an escalation of diabetes medication. I’ll share my top 5 drugs that cause...
by Eric Christianson | Sep 15, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Many drugs cause insomnia. What is most frustrating to me in my practice is when we start medications for a “new condition” prior to ruling out medication adverse effects. Here is the list of my top 5 drugs that cause insomnia (an important adverse...
by Eric Christianson | Sep 11, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
by Eric Christianson | Sep 8, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
In this blog post, I want to share some important SSRI clinical pearls that help clinicians decide which of these antidepressants to use. Note that these clinical practice pearls are good examples of some testable items that may show up on your board exam 🙂 Sertraline...
